http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015268647-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_434c1b910eb8a84738a28d2d600bce4b |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate | 2015-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f59eb7b454d077f891e77f91d044e756 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48ee9851491ff12a79904d4912b2b101 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7899b73e8c26da320445557e7acb606e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63e8e05372c992cc409cd3c87f8a23fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf0759d75d5ed3988807af2d488bc17e |
publicationDate | 2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2015268647-A1 |
titleOfInvention | Corticosteroids for the Treatment of Joint Pain |
abstract | Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production. |
priorityDate | 2010-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 552.